Skip to main navigation
Work With Us
Contact
Home
About Us
Science
Publications
Pipeline
UBX1325
Clinical Trials
Investors & Media
Corporate Overview
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
Investor Resources
Work With Us
Contact
Menu
Menu
Event Details
Submenu
Corporate Overview
Press Releases
Events & Presentations
Corporate Governance
Governance Documents
Board of Directors
Executive Team
Committee Composition
Board Diversity Matrix
SEC Filings
Stock Information
Stock Quote & Chart
Analyst Coverage
Investor Resources
Contact IR
Investor FAQs
Investor Tools
Print Page
Email Page
Contact IR
Email Alerts
RSS Feeds
Phase 2 ENVISION Program Update Call
March 27, 2023
8:00 AM EDT
Click here for webcast
Scroll to top